Blog

Discover Galderma's new trial insights on menopause and weight loss skin changes, highlighting Restylane and Sculptra for facial and body...

New research explores how Dupilumab, an immune-targeting drug for atopic dermatitis, may help treat depression by addressing inflammation’s role.

Rezpegaldesleukin shows promising 52-week hair regrowth results in severe alopecia areata by restoring immune balance and activating regulatory T cells.

Discover the latest breakthroughs in inflammatory skin disease management, from metabolic drivers to new biologic therapies shaping psoriasis and eczema...

Discover the latest insights and emerging treatments for rosacea in 2024. Learn about causes, symptoms, and how to manage this...

Discover how culture and stigma deeply affect mental health and quality of life for vitiligo patients, revealing the hidden psychosocial...

Upadacitinib shows promising repigmentation results in phase 3 vitiligo trials, offering hope for effective treatment of non-segmental vitiligo.

Discover how oral JAK inhibitors are transforming vitiligo treatment, offering deeper repigmentation beyond traditional topical creams and phototherapy.